{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:36:50Z","timestamp":1773664610250,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1479-5876-9-84","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T18:23:42Z","timestamp":1306952622000},"source":"Crossref","is-referenced-by-count":32,"title":["Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1"],"prefix":"10.1186","volume":"9","author":[{"given":"Pavel","family":"M\u00e1jek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Reicheltov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Suttnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Mal\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Oravec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kl\u00e1ra","family":"Pe\u010d\u00e1nkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan E","family":"Dyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"738_CR1","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","volume":"24","author":"G De Backer","year":"2003","unstructured":"De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gom\u00e9r K, Perk J, Py\u00f6r\u00e4l\u00e4 K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003, 24: 1601-1610. 10.1016\/S0195-668X(03)00347-6.","journal-title":"Eur Heart J"},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ahj.2003.09.010","volume":"147","author":"K Dunder","year":"2004","unstructured":"Dunder K, Lind L, Lagerqvist B, Zethelius B, Vessby B, Lithell H: Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction. Am Heart J. 2004, 147: 502-508. 10.1016\/j.ahj.2003.09.010.","journal-title":"Am Heart J"},{"key":"738_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1479-5876-6-46","volume":"6","author":"KA Schwartz","year":"2008","unstructured":"Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC: Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med. 2008, 6: 46-10.1186\/1479-5876-6-46.","journal-title":"J Transl Med"},{"key":"738_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11883-009-0030-x","volume":"11","author":"A Didangelos","year":"2009","unstructured":"Didangelos A, Simper D, Monaco C, Mayr M: Proteomics of acute coronary syndromes. Curr Atheroscler Rep. 2009, 11: 188-195. 10.1007\/s11883-009-0030-x.","journal-title":"Curr Atheroscler Rep"},{"key":"738_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCGENETICS.108.813337","volume":"1","author":"CJ O'Donnell","year":"2008","unstructured":"O'Donnell CJ, Nabel EG: Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era. Circ Cardiovasc Genet. 2008, 1: 51-57. 10.1161\/CIRCGENETICS.108.813337.","journal-title":"Circ Cardiovasc Genet"},{"key":"738_CR6","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jacc.2006.06.063","volume":"48","author":"S Arab","year":"2006","unstructured":"Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, van Eyk J, Ouzounian M, MacLennan DH, Emili A, Liu PP: Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol. 2006, 48: 1733-1741. 10.1016\/j.jacc.2006.06.063.","journal-title":"J Am Coll Cardiol"},{"key":"738_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1479-5876-8-24","volume":"8","author":"CS Sondergaard","year":"2010","unstructured":"Sondergaard CS, Hess DA, Maxwell DJ, Weinheimer C, Rosov\u00e1 I, Creer MH, Piwnica-Worms D, Kovacs A, Pedersen L, Nolta JA: Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med. 2010, 8: 24-10.1186\/1479-5876-8-24.","journal-title":"J Transl Med"},{"key":"738_CR8","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1128\/MCB.19.3.1720","volume":"19","author":"SP Gygi","year":"1999","unstructured":"Gygi SP, Rochon Y, Franza BR, Aebersold R: Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. 1999, 19: 1720-1730.","journal-title":"Mol Cell Biol"},{"key":"738_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1155\/2004\/965261","volume":"20","author":"BA Stanley","year":"2004","unstructured":"Stanley BA, Gundry RL, Cotter RJ, Van Eyk JE: Heart disease, clinical proteomics and mass spectrometry. Dis Markers. 2004, 20: 167-178.","journal-title":"Dis Markers"},{"key":"738_CR10","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1002\/pmic.200401308","volume":"5","author":"BT Berhane","year":"2005","unstructured":"Berhane BT, Zong C, Liem DA, Huang A, Le S, Edmondson RD, Jones RC, Qiao X, Whitelegge JP, Ping P, Vondriska TM: Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics. 2005, 5: 3520-3530. 10.1002\/pmic.200401308.","journal-title":"Proteomics"},{"key":"738_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L","volume":"192","author":"G Chambers","year":"2000","unstructured":"Chambers G, Lawrie L, Cash P, Murray GI: Proteomics: a new approach to the study of disease. J Pathol. 2000, 192: 280-288. 10.1002\/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L.","journal-title":"J Pathol"},{"key":"738_CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-5956-8-56","volume":"8","author":"P M\u00e1jek","year":"2010","unstructured":"M\u00e1jek P, Reicheltov\u00e1 Z, Stikarov\u00e1 J, Suttnar J, Sobotkov\u00e1 A, Dyr JE: Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin. Proteome Sci. 2010, 8: 56-","journal-title":"Proteome Sci"},{"key":"738_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1182\/blood-2002-10-3150","volume":"102","author":"AV Cooper","year":"2003","unstructured":"Cooper AV, Standeven KF, Ari\u00ebns RA: Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood. 2003, 102: 535-540. 10.1182\/blood-2002-10-3150.","journal-title":"Blood"},{"key":"738_CR14","doi-asserted-by":"publisher","first-page":"33846","DOI":"10.1074\/jbc.M805522200","volume":"283","author":"I Parastatidis","year":"2008","unstructured":"Parastatidis I, Thomson L, Burke A, Chernysh I, Nagaswami C, Visser J, Stamer S, Liebler DC, Koliakos G, Heijnen HF, Fitzgerald GA, Weisel JW, Ischiropoulos H: Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. J Biol Chem. 2008, 283: 33846-33853. 10.1074\/jbc.M805522200.","journal-title":"J Biol Chem"},{"key":"738_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tibtech.2004.05.001","volume":"22","author":"PT Gomme","year":"2004","unstructured":"Gomme PT, Bertolini J: Therapeutic potential of vitamin D-binding protein. Trends Biotechnol. 2004, 22: 340-345. 10.1016\/j.tibtech.2004.05.001.","journal-title":"Trends Biotechnol"},{"key":"738_CR16","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1021\/pr060600i","volume":"6","author":"AJ L\u00f3pez-Farr\u00e9","year":"2007","unstructured":"L\u00f3pez-Farr\u00e9 AJ, Mateos-C\u00e1ceres PJ, Sacrist\u00e1n D, Azcona L, Bernardo E, de Prada TP, Alonso-Orgaz S, Fern\u00e1ndez-Arquero M, Fern\u00e1ndez-Ortiz A, Macaya C: Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res. 2007, 6: 2481-2487. 10.1021\/pr060600i.","journal-title":"J Proteome Res"},{"key":"738_CR17","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1016\/S0021-9258(17)41933-8","volume":"269","author":"H Itoh","year":"1994","unstructured":"Itoh H, Ide H, Ishikawa N, Nawa Y: Mast cell protease inhibitor, trypstatin, is a fragment of inter-alpha-trypsin inhibitor light chain. J Biol Chem. 1994, 269: 3818-3822.","journal-title":"J Biol Chem"},{"key":"738_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1046\/j.1523-1747.2003.12409.x","volume":"121","author":"M Allhorn","year":"2003","unstructured":"Allhorn M, Lundqvist K, Schmidtchen A, Akerstr\u00f6m B: Heme-scavenging role of alpha1-microglobulin in chronic ulcers. J Invest Dermatol. 2003, 121: 640-646. 10.1046\/j.1523-1747.2003.12409.x.","journal-title":"J Invest Dermatol"},{"key":"738_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.amjhyper.2007.01.010","volume":"20","author":"GP Vyssoulis","year":"2007","unstructured":"Vyssoulis GP, Tousoulis D, Antoniades C, Dimitrakopoulos S, Zervoudaki A, Stefanadis C: Alpha-1 microglobulin as a new inflammatory marker in newly diagnosed hypertensive patients. Am J Hypertens. 2007, 20: 1016-1021. 10.1016\/j.amjhyper.2007.01.010.","journal-title":"Am J Hypertens"},{"key":"738_CR20","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.jacc.2004.06.073","volume":"44","author":"PJ Mateos-C\u00e1ceres","year":"2004","unstructured":"Mateos-C\u00e1ceres PJ, Garc\u00eda-M\u00e9ndez A, L\u00f3pez Farr\u00e9 A, Macaya C, N\u00fa\u00f1ez A, G\u00f3mez J, Alonso-Orgaz S, Carrasco C, Burgos ME, de Andr\u00e9s R, Granizo JJ, Farr\u00e9 J, Rico LA: Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol. 2004, 44: 1578-1583. 10.1016\/j.jacc.2004.06.073.","journal-title":"J Am Coll Cardiol"},{"key":"738_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0021-9150(87)90091-8","volume":"68","author":"P Puchois","year":"1987","unstructured":"Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC: Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis. 1987, 68: 35-40. 10.1016\/0021-9150(87)90091-8.","journal-title":"Atherosclerosis"},{"key":"738_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2362.1978.tb00832.x","volume":"8","author":"T Ishikawa","year":"1978","unstructured":"Ishikawa T, Fidge N, Thelle DS, F\u00f8rde OH, Miller NE: The Troms\u00f8 Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease. Eur J Clin Invest. 1978, 8: 179-182. 10.1111\/j.1365-2362.1978.tb00832.x.","journal-title":"Eur J Clin Invest"},{"key":"738_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/archinte.1990.00040031629009","volume":"150","author":"RA Reinhart","year":"1990","unstructured":"Reinhart RA, Gani K, Arndt MR, Broste SK: Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease. Arch Intern Med. 1990, 150: 1629-1633. 10.1001\/archinte.150.8.1629.","journal-title":"Arch Intern Med"},{"key":"738_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/prca.200780157","volume":"2","author":"G Candiano","year":"2008","unstructured":"Candiano G, Bruschi M, Petretto A, Santucci L, Del Boccio P, Urbani A, Bertoni E, Gusmano R, Salvadori M, Scolari F, Ghiggeri GM: Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms. Proteomics Clin Appl. 2008, 2: 956-963. 10.1002\/prca.200780157.","journal-title":"Proteomics Clin Appl"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-9-84\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T12:39:27Z","timestamp":1637757567000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-9-84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-9-84","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,1]]},"article-number":"84"}}